Kelly C, Pericleous M, Ahmed A, et al. Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions—a prospective descriptive study. Int J Infect Dis. 2020;100:264-272.
Sweeney L, Owiti J, Beharry A, et al. Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals. BMC Health Serv Res. 2015;15:97.
Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016. Hepatology. 2019;69:1020-1031.
Wong RJ, Jain MK, Therapondos G, et al. Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment. Am J Gastroenterol. 2018;113:1329-1338.
Reilley B and Leston J. A Tale of Two Epidemics—HCV treatment among Native Americans and veterans. N Engl J Med. 2017;377:801-803.
Trickey A, Fraser H, Lim AG, et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastro Hep. 2019;4:435-444.
Kandeel AM, Talaat M, Afifi SA, et al. Case control study to identify risk factors for acute hepatitis C virus infection in Egypt. BMC Infectious Diseases. 2012;12:294.
Falla AM, Veldhuijzen IK, Ahmad AA, et al. Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians’ perceptions of language barriers in six European countries. BMC Health Serv Res. 2017;17:150.
Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364:2199-2207.
Uddin G, Shoeb D, Solaiman S, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat. 2010;17:327-335.
Smout E, Williams J, Miners A, et al. Get Tested LeEDs: clinical impact and cost-effectiveness of opt-out emergency department testing for bloodborne viruses (BBVs). Presented at: 2021 European Association for the Study of the Liver International Liver Congress™; June 23-26, 2021. Abstract OS-199.
Sulkowski M. Concordance of SVR 4-12-24 timepoints in an era of reduced sustained virologic response (SVR) determination. Presented at: 2021 European Association for the Study of the Liver International Liver Congress™; June 23-26, 2021. Abstract 983.